BACKGROUND: Adiponectin is secreted by adipose tissue and exerts high abundance and an anti-inflammatory potential. However, only little information exists about the expression profiles of adiponectin and its recently identified receptor CDH13 in non-tumorous human tissues and their association to clinical parameters. METHODS: The expression levels of adiponectin and CDH13 were analyzed in heart, liver, kidney, spleen, skin, blood vessels, peripheral nerve and bone marrow of 21 human body donors, in 12 human cell lines, and in purified immune effector cell populations of healthy blood donors by immunohistochemistry, Western-blot, and semi-quantitative PCR. The obtained results were then correlated to clinical parameters, including age, sex and known diseases like cardiovascular and renal diseases. RESULTS: Adiponectin expression in renal corpuscles was significantly higher in humans with known renal diseases. A coordinated expression of adiponectin and CDH13 was observed in the myocard. High levels of adiponectin could be detected in the bone marrow, in certain lymphoid tumor cell lines and in purified immune effector cell populations of healthy donors, in particular in cytotoxic T cells. CONCLUSION: For the first time, the expression profiles of adiponectin and CDH13 are analyzed in many human tissues in correlation to each other and to clinical parameters.
BACKGROUND:Adiponectin is secreted by adipose tissue and exerts high abundance and an anti-inflammatory potential. However, only little information exists about the expression profiles of adiponectin and its recently identified receptor CDH13 in non-tumoroushuman tissues and their association to clinical parameters. METHODS: The expression levels of adiponectin and CDH13 were analyzed in heart, liver, kidney, spleen, skin, blood vessels, peripheral nerve and bone marrow of 21 human body donors, in 12 human cell lines, and in purified immune effector cell populations of healthy blood donors by immunohistochemistry, Western-blot, and semi-quantitative PCR. The obtained results were then correlated to clinical parameters, including age, sex and known diseases like cardiovascular and renal diseases. RESULTS:Adiponectin expression in renal corpuscles was significantly higher in humans with known renal diseases. A coordinated expression of adiponectin and CDH13 was observed in the myocard. High levels of adiponectin could be detected in the bone marrow, in certain lymphoid tumor cell lines and in purified immune effector cell populations of healthy donors, in particular in cytotoxic T cells. CONCLUSION: For the first time, the expression profiles of adiponectin and CDH13 are analyzed in many human tissues in correlation to each other and to clinical parameters.
Authors: Sonja A Dames; Eunjung Bang; Daniel Haüssinger; Thomas Ahrens; Jürgen Engel; Stephan Grzesiek Journal: J Biol Chem Date: 2008-06-10 Impact factor: 5.157
Authors: Daniel Guenther; Stefan Schmidl; Till O Klatte; Harald K Widhalm; Mohamed Omar; Christian Krettek; Thorsten Gehrke; Daniel Kendoff; Carl Haasper Journal: World J Orthop Date: 2015-01-18
Authors: Christopher Hug; Jin Wang; Naina Shehzeen Ahmad; Jonathan S Bogan; Tsu-Shuen Tsao; Harvey F Lodish Journal: Proc Natl Acad Sci U S A Date: 2004-06-21 Impact factor: 11.205
Authors: Johannes Fänder; Heike Kielstein; Maximilian Büttner; Peter Koelblinger; Reinhard Dummer; Marcus Bauer; Diana Handke; Claudia Wickenhauser; Barbara Seliger; Simon Jasinski-Bergner Journal: Oncotarget Date: 2019-11-05